RI Doctor and former Brown Prof. Sentenced to 51 Months for Opioid Kickback Scheme

GoLocalProv News Team

RI Doctor and former Brown Prof. Sentenced to 51 Months for Opioid Kickback Scheme

Rosenberg sentenced to 51 months for the scheme
A Rhode Island doctor and former Brown University professor was sentenced to federal prison for healthcare fraud tied to opioid kickbacks.

Dr. Jerrold Rosenberg, 63, of Warren, the operator of a now-defunct pain management practice in Rhode Island, was sentenced to 51 months in federal prison for committing healthcare fraud and for conspiring to solicit and receive kickbacks in return for prescribing the drug Subsys, a fast-acting, powerful, and highly-addictive version of the opioid drug Fentanyl.  Rosenberg, who was a professor at Brown University, has been fired from that post.

Subsys is manufactured by Arizona based company Insys Therapeutics, Inc. (“Insys”). The under-the-tongue spray was approved by the U.S. Food and Drug Administration in 2012 exclusively for “the management of breakthrough cancer pain in patients who are already receiving and who are already tolerant of opioid therapy for their underlying persistent cancer pain.”

GET THE LATEST BREAKING NEWS HERE -- SIGN UP FOR GOLOCAL FREE DAILY EBLAST

As a result, many insurance companies require a diagnosis of breakthrough cancer pain before approving coverage of the drug, which costs approximately $2,000 to over $16,000 for a thirty day supply.

The Sentencing

At the sentencing hearing, three former patients of Dr. Rosenberg testified about the severe and debilitating effects they experienced from taking Subsys. Some witnesses testified to the doctor’s indifference to their complaints and pleas to be taken off Subsys.

Rosenberg pleaded guilty on October 25, 2017, to healthcare fraud and conspiracy to receive kickbacks. At the time of his guilty plea, Rosenberg admitted to the Court that between 2012 and 2015, he carried out a healthcare fraud scheme in which he made false representations to insurers, both private and government-funded, claiming patients met the insurance criteria of having breakthrough cancer pain when he knew that they, in fact, did not, in order to secure approvals and payment for prescriptions of Subsys. Rosenberg admitted that, in total, the healthcare fraud scheme resulted in losses of over $750,000; in many cases, the cost of the drug was reimbursed, at least in part, by the Medicare program.

Additionally, Rosenberg admitted that, between 2012 and 2015, he conspired with Insys officials to receive kickbacks, in the form of purported speaker fees, from the manufacturer of the spray. 

Rosenberg admitted that he accepted these payments, which totaled over $188,000. In addition, according to court documents, Rosenberg’s son was a sales representative for Insys Therapeutics from June 2012 – September 2013, and made substantial amounts in commissions as a result of the defendant’s prescribing Subsys to his patients.  Rosenberg admitted that the speaking fees he received from Insys were a significant motivating factor in his decision to prescribe Subsys to his patients.

According to Bloomberg, "Rosenberg’s son was an Insys sales representative for a year and made 'substantial commissions' from his father’s willingness to prescribe the drug, according to prosecutors. The son wasn’t charged in the case."

The U.S. Sentencing guideline range of imprisonment in this matter is 51-63 months. The government recommended the court impose a sentence of 63 months incarceration. At sentencing, the Court also ordered Rosenberg to pay restitution in the amount of $754,736.48 to the Medicare program.


17 Biggest News Stories of 2017

Enjoy this post? Share it with others.